Sep 29, 2025Low $163.20 · High $245.36Sep 28, 2026
What changed · written from our data
As of Sep 28, 2026
VanEck Biotech ETF closed at $245.34 on Sep 28, down 0.01% — matching its 52-week closing high. Volume of 10.3K shares was 0.83× its 20-day average (close to normal).
Split-adjusted performance: +1.4% over one month, +36.3% over six months, +52.4% over one year.
Short interest was 21.8K shares at the Sep 15 settlement, up 2.7% from the prior report (1.5 days to cover).
Yes. The latest regular dividend was $0.9565 per share (ex-date Dec 22), an annualised yield of 0.39%.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology